Davidson KR, Ha DM, Schwarz MI, Chan ED. Bronchoalveolar lavage as a diagnostic procedure: a review of known cellular and molecular findings in various lung diseases. J Thorac Dis. 2020 Sep;12(9):4991-5019. PubMed PMID: 33145073
Ha D, Ries AL, Lippman SM, Fuster MM. Effects of curative-intent lung cancer therapy on functional exercise capacity and patient-reported outcomes. Support Care Cancer. 2020 Oct;28(10):4707-4720. PubMed PMID: 31965306
Ha D, Ries AL. Characterization of Dyspnea in Veteran Lung Cancer Survivors Following Curative-Intent Therapy. J Cardiopulm Rehabil Prev. 2020 Mar;40(2):120-127. PubMed PMID: 31592931
Ha D, Kerr J, Ries AL, Fuster MM, Lippman SM, Murphy JD. A Model-Based Cost-Effectiveness Analysis of an Exercise Program for Lung Cancer Survivors After Curative-Intent Treatment. Am J Phys Med Rehabil. 2020 Mar;99(3):233-240. PubMed PMID: 31361623
Ha D, Malhotra A, Ries AL, O'Neal WT, Fuster MM. Heart rate variability and heart rate recovery in lung cancer survivors eligible for long-term cure. Respir Physiol Neurobiol. 2019 Nov;269:103264. PubMed PMID: 31376471
Liu D, Wen H, He J, Gao S, Li S, Liu L, He J, Huang Y, Xu S, Mao W, Tan Q, Chen C, Li X, Zhang Z, Jiang G, Xu L, Zhang L, Fu J, Li H, Wang Q, Tan L, Li D, Zhou Q, Fu X, Jiang Z, Chen H, Fang W, Zhang X, Li Y, Tong T, Yu Z, Liu Y, Zhi X, Yan T, Zhang X, Brunelli A, Salati M, Phan K, Hida Y, Venuta F, Choi JH, Papagiannopoulos K, Ha D, Novoa N. Society for Translational Medicine Expert Consensus on the preoperative assessment of circulatory and cardiac functions and criteria for the assessment of risk factors in patients with lung cancer. J Thorac Dis. 2018 Sep;10(9):5545-5549. PubMed PMID: 30416805
Ha D, Ries AL, Mazzone PJ, Lippman SM, Fuster MM. Exercise capacity and cancer-specific quality of life following curative intent treatment of stage I-IIIA lung cancer. Support Care Cancer. 2018 Jul;26(7):2459-2469. PubMed PMID: 29429006
Ha D, Ries AL, Montgrain P, Vaida F, Sheinkman S, Fuster MM. Time to treatment and survival in veterans with lung cancer eligible for curative intent therapy. Respir Med. 2018 Aug;141:172-179. PubMed PMID: 30053964
Ha D, Mazzone PJ, Ries AL, Malhotra A, Fuster M. The Utility of Exercise Testing in Patients with Lung Cancer. J Thorac Oncol. 2016 Sep;11(9):1397-410. PubMed PMID: 27156441
Ha D, Liao X, Wang HY, Jamieson C, Magaña M, Makani S. Thoracic Extramedullary Hematopoiesis Mimicking Metastatic Cancer. J Bronchology Interv Pulmonol. 2016 Oct;23(4):343-346. PubMed PMID: 27479013
Tejwani V, Ha D, Isada C. Observations: Public Speaking Anxiety in Graduate Medical Education--A Matter of Interpersonal and Communication Skills?. J Grad Med Educ. 2016 Feb;8(1):111. PubMed PMID: 26913118
Ha D, Fuster M, Ries AL, Wagner PD, Mazzone PJ. Heart Rate Recovery as a Preoperative Test of Perioperative Complication Risk. Ann Thorac Surg. 2015 Nov;100(5):1954-62. PubMed PMID: 26410158
Ha D, Choi H, Chevalier C, Zell K, Wang XF, Mazzone PJ. Survival in patients with metachronous second primary lung cancer. Ann Am Thorac Soc. 2015 Jan;12(1):79-84. PubMed PMID: 25494009
Ha D, Choi H, Zell K, Raymond DP, Stephans K, Wang XF, Videtic G, McCarthy K, Minai OA, Mazzone PJ. Association of impaired heart rate recovery with cardiopulmonary complications after lung cancer resection surgery. J Thorac Cardiovasc Surg. 2015 Apr;149(4):1168-73.e3. PubMed PMID: 25583106
Ha D, Stephans K, Choi H, Zell K, Wang XF, Minai OA, Raymond DP, Videtic G, Mazzone PJ. Heart rate recovery and survival in patients undergoing stereotactic body radiotherapy for treatment of early-stage lung cancer. J Radiosurg SBRT. 2015;3(3):193-201. PubMed PMID: 29296402
Albeldawi M, Ha D, Mehta P, Lopez R, Jang S, Sanaka MR, Vargo JJ. Utility of urgent colonoscopy in acute lower gastro-intestinal bleeding: a single-center experience. Gastroenterol Rep (Oxf). 2014 Nov;2(4):300-5. PubMed PMID: 24958253
Ha D, Faulx M, Isada C, Kattan M, Yu C, Olender J, Nielsen C, Brateanu A. Transitioning from a noon conference to an academic half-day curriculum model: effect on medical knowledge acquisition and learning satisfaction. J Grad Med Educ. 2014 Mar;6(1):93-9. PubMed PMID: 24701317
Ha D, Mester J, Eng C, Farha S. Pulmonary arterial hypertension in a patient with Cowden syndrome and the PTEN mutation. Pulm Circ. 2014 Dec;4(4):728-31. PubMed PMID: 25610608
Ha D, Choi H, Almeida FA, Arrossi A, Brainard J, Cicenia J, Farver C, Gildea T, Machuzak MS, Mazzone P. Histologic and molecular characterization of lung cancer with tissue obtained by electromagnetic navigation bronchoscopy. J Bronchology Interv Pulmonol. 2013 Jan;20(1):10-5. PubMed PMID: 23328135
Ha DM, Zeng C, Chan ED, Gray M, Mazzone PJ, Samet JM, Steiner JF. Association of Exercise Behavior with Overall Survival in Stage I-IIIA Lung Cancer. Ann Am Thorac Soc. 2021 Jun;18(6):1034-1042. doi: 10.1513/AnnalsATS.202003-235OC. PMID: 33326358.
Ha DM, Prochazka AV, Bekelman DB, Stevens-Lapsley JE, Studts JL, Keith RL. Modifiable factors associated with health-related quality of life among lung cancer survivors following curative intent therapy. Lung Cancer. 2022 Jan;163:42-50. PubMed PMID: 34896804
Lee Y, Ise T, Ha D, Saint Fleur A, Hahn Y, Liu XF, Nagata S, Lee B, Bera TK, Pastan I. Evolution and expression of chimeric POTE-actin genes in the human genome. Proc Natl Acad Sci U S A. 2006 Nov 21;103(47):17885-90. PubMed PMID: 17101985
Sato H, Dalton LA, Ha D, Quine RW, Eaton SS, Eaton GR. Electron spin relaxation in x-lithium phthalocyanine. J Phys Chem B. 2007 Jul 19;111(28):7972-7. PubMed PMID: 17583936
Bera TK, Saint Fleur A, Ha D, Yamada M, Lee Y, Lee B, Hahn Y, Kaufman DS, Pera M, Pastan I. Selective POTE paralogs on chromosome 2 are expressed in human embryonic stem cells. Stem Cells Dev. 2008 Apr;17(2):325-32. PubMed PMID: 18447647
Anaganti S, Hansen JK, Ha D, Hahn Y, Chertov O, Pastan I, Bera TK. Non-AUG translational initiation of a short CAPC transcript generating protein isoform. Biochem Biophys Res Commun. 2009 Mar 13;380(3):508-13. PubMed PMID: 19250639
Ha DM, Deng LR, Lange AV, Swigris JJ, Bekelman DB. Reliability, Validity, and Responsiveness of the DEG, a Three-Item Dyspnea Measure. J Gen Intern Med. 2022 Jan 3. [Epub ahead of print] PubMed PMID: 34981344
Ha DM, Prochazka AV, Bekelman DB, Stevens-Lapsley JE, Chan ED, Keith RL. Association of Leisure-Time Physical Activity With Health-Related Quality of Life Among US Lung Cancer Survivors. JNCI Cancer Spectr. 2021 Feb;5(1):pkaa118. PubMed PMID: 35075444
Bade BC, Faiz SA, Ha DM, Tan M, Barton-Burke M, Cheville AL, Escalante CP, Gozal D, Granger CL, Presley CJ, Smith SM, Chamberlaine DM, Long JM, Malone DJ, Pirl WF, Robinson HL, Yasufuku K, Rivera MP. Cancer-related Fatigue in Lung Cancer: A Research Agenda: An Official American Thoracic Society Research Statement. Am J Respir Crit Care Med. 2023 Mar 1;207(5):e6-e28. PubMed PMID: 36856560
Ha DM, Nunnery MA, Klocko RP, Haverhals LM, Bekelman DB, New ML, Randhawa SK, Stevens-Lapsley JE, Studts JL, Prochazka AV, Keith RL. Lung cancer survivors' views on telerehabilitation following curative intent therapy: a formative qualitative study. BMJ Open. 2023 Jun 23;13(6):e073251. PubMed PMID: 37355268
Ha, D.M. (2023). Physiologic and Patient-Centered Considerations in Lung Cancer Care. In: MacRosty, C.R., Rivera, M.P. (eds) Lung Cancer. Respiratory Medicine. Humana, Cham. https://doi.org/10.1007/978-3-031-38412-7_13
Ha DM, Comer A, Dollar B, Bedoy R, Ford M, Gozansky WS, Zeng C, Arch JJ, Leach HJ, Malhotra A, Prochazka AV, Keith RL, Boxer RS. Telemedicine-based inspiratory muscle training and walking promotion with lung cancer survivors following curative intent therapy: a parallel-group pilot randomized trial. Support Care Cancer. 2023 Sep 1;31(9):546. PubMed PMID: 37656252
Ries AL, Ha DM. Rehabilitation in Chronic Obstructive Pulmonary Disease and Other Respiratory Disorders. In Fishman’s Pulmonary Diseases and Disorders, 6th ed. Grippi MA, Antin-Ozerkis DE, Dela Cruz CS, eds. McGraw-Hill.
Miller YE, Ghosh M, Merrick DT, Kubala B, Szabo E, Bengtson L, Kocherginsky M, Helenowski IB, Benante K, Schering T, Kim J, Kim H, Ha D, Bergan RC, Khan SA, Keith RL. Phase Ib trial of inhaled iloprost for the prevention of lung cancer with predictive and response biomarker assessment. Front Oncol. 2023;13:1204726. PubMed PMID: 37711198